Top Markets
Coin of the day
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
Rankning i aktier #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
Aktiekurs
$64.97
Senast synkroniserad: 2024-05-20
Marknadsvärde
$1.97B
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Alpine Immune Sciences, Inc. (ALPN)

Kategori

P/B-tal för Alpine Immune Sciences, Inc. (ALPN)
P/B-tal per August 2026 TTM: 9.91
Enligt Alpine Immune Sciences, Inc. senaste finansiella rapporter och aktiekurs är det aktuella P/B-talet (TTM) 9.91. I slutet av 2022 hade företaget ett P/B-tal på 1.37.
Historik för P/B-tal för Alpine Immune Sciences, Inc. från 2012 till 2026
P/B-tal vid årets slut
År P/B-tal Ändra
2026 (TTM) 9.91 240.41%
2023 2.91 112.16%
2022 1.37 -53.07%
2021 2.92 -30.87%
2020 4.22 76.50%
2019 2.39 109.27%
2018 1.14 24.25%
2017 0.92 46.95%
2016 0.63 -27.94%
2015 0.87 -110.05%
2014 -8.64 479.51%
2013 -1.49 0.00%
2012 0.00 0.00%
P/B-tal för liknande företag eller konkurrenter
Företag P/B-tal Skillnad i P/B-tal Land
6.3419 -35.98%
US
6.2413 -36.99%
NL
2.5054 -74.71%
AU
3.7087 -62.56%
US
- -
CH